BBH - Long ideaWe made a new high. Retested the old high as support. And are consolidating above the new support now. A bit more consolidation leading into buy signals from the MACD and Stoch would be a good long signal.
Key stats
About VanEck Biotech ETF
Expense ratio
0.35%
Home page
Inception date
Dec 20, 2011
BBH offers a more concentrated take on the global biotech industry. Although the space is already dominated by US firms, the fund aims to select just 25 US listed companies by market cap, also weighing each constituent by market cap. The underlying index has a flexible definition of biotech, encompassing companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment, excluding pharmacies. Also, despite capping its issuers to a maximum of 20%, the fund may still be top heavy due to the indexs concentrated nature. Overall, BBH is a viable take on this market. The index is reviewed semi-annually.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Biotech Ideas Long termShort for the mid term and long for long after that. Short at this numbers and looking to see what happens in the short term testinf the MA50 months.
#BBH - Breakout... time to buy this stockNice opportunity to buy #BBH stocks. We have triangle and breakout. It's strong signal to buy.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.